Genes involved in this process that are commonly mutated in MPN include DNMT3A, TET2 and IDH1/2. Samples from MPN patients show aberrant DNA methylation patterns in comparison to controls and this changes again during transformation to blast phase of disease [99]. This evidence concerns the gene TET2 and myeloproliferative neoplasm.